Neuphoria Therapeutics
NEUP
9 hedge funds and large institutions have $1.26M invested in Neuphoria Therapeutics in 2025 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 0 closing their positions.
35% more capital invested
Capital invested by funds: $935K → $1.26M (+$328K)
29% more funds holding
Funds holding: 7 → 9 (+2)
0.2% more ownership
Funds ownership: 9.27% → 9.47% (+0.2%)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$84.8K |
| 2 |
PWM
Prosperity Wealth Management
San Ramon,
California
|
+$14.8K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$6 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AI
AdvisorShares Investments
Bethesda,
Maryland
|
-$11.2K |
| 2 |
RhumbLine Advisers
Boston,
Massachusetts
|
-$2.22K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AI
1
AdvisorShares Investments
Bethesda,
Maryland
| $481K | -$11.2K | -1,926 | -3% |
|
|
LCM
2
Lynx1 Capital Management
San Juan,
Puerto Rico
| $325K | – | – | – |
|
|
PWM
3
Prosperity Wealth Management
San Ramon,
California
| $211K | +$14.8K | +2,550 | +9% |
|
|
4
Citadel Advisors
Miami,
Florida
| $104K | +$84.8K | +14,606 | New |
|
|
MC
5
Merck & Co
Kenilworth,
New Jersey
| $71.2K | – | – | – |
|
|
CWP
6
Cyndeo Wealth Partners
St. Petersburg,
Florida
| $71K | – | – | – |
|
|
7
RhumbLine Advisers
Boston,
Massachusetts
| $234 | -$2.22K | -382 | -92% |
|
8
Morgan Stanley
New York
| $50 | – | – | – |
|
|
9
Bank of America
Charlotte,
North Carolina
| $7 | +$6 | +1 | New |
|
NEUP Hedge Fund Activity: Q2 2025 in Review
9 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Neuphoria Therapeutics (NEUP) for Q2 2025, worth a combined $1.26M — up 35% from $935K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new NEUP positions and 0 closed out — a net gain of 2 holders — while 1 added to existing stakes and 2 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $84.8K. The largest seller was AdvisorShares Investments, cutting an estimated $11.2K.
- 9 institutional investors held Neuphoria Therapeutics (NEUP) as of Q2 2025, up from 7 in Q1 2025.
- Funds reported $1.26M of Neuphoria Therapeutics stock for Q2 2025, up 35% quarter-over-quarter.
- 2 funds opened new Neuphoria Therapeutics positions in Q2 2025 and 0 closed out, a net change of +2 holders.
- The largest Neuphoria Therapeutics buyer in Q2 2025 was Citadel Advisors, an estimated $84.8K added.
- The largest Neuphoria Therapeutics seller in Q2 2025 was AdvisorShares Investments, an estimated $11.2K sold.
Based on aggregated 13F filings for Q2 2025.